Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Berger

Showing results (671-680 of 774) with videos related to

Pageof 78
Sort By:
JAMA|March 15, 2006
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trialAdnan Kastrati, Julinda Mehilli, Franz-Josef Neumann, et al.
North Carolina Medical Journal|July 12, 2018
Implementation of the North Carolina HIV Bridge Counseling Program to Facilitate Linkage and Reengagement in Care for Individuals Infected with HIV/AIDSH Swygard, Arlene C Seña, V Mobley, et al.
Journal of the American College of Cardiology|November 14, 2009
The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysisJeffrey S Berger, Deepak L Bhatt, Christopher P Cannon, et al.
Regulatory Toxicology and Pharmacology : RTP|October 13, 2000
Concordance of the toxicity of pharmaceuticals in humans and in animalsH Olson, G Betton, D Robinson, et al.
The American Journal of Cardiology|January 21, 2014
Comparison of intermediate-term outcomes of coronary artery bypass grafting versus drug-eluting stents for patients ≥75 years of ageEdward L Hannan, Ye Zhong, Peter B Berger, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 21, 2012
In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registryPaul H Tolerico, David J Cohen, Neal S Kleiman, et al.
The American Journal of Cardiology|November 25, 2010
Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trialJames C Blankenship, Kimberly A Skelding, Thomas D Scott, et al.
Nature Immunology|September 7, 2010
SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophagesScott B Berger, Xavier Romero, Chunyan Ma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 5, 2013
One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trialStefanie Schulz, Adnan Kastrati, Miroslaw Ferenc, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 1, 2023
Impact of COVID-19 on percutaneous coronary intervention utilization and mortality in New YorkEdward L Hannan, Ye Zhong, Kimberly Cozzens, et al.
Pageof 78

Showing results (671-680 of 774) with videos related to

Sort By:
Pageof 78
JAMA|March 15, 2006
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trialAdnan Kastrati, Julinda Mehilli, Franz-Josef Neumann, et al.
North Carolina Medical Journal|July 12, 2018
Implementation of the North Carolina HIV Bridge Counseling Program to Facilitate Linkage and Reengagement in Care for Individuals Infected with HIV/AIDSH Swygard, Arlene C Seña, V Mobley, et al.
Journal of the American College of Cardiology|November 14, 2009
The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysisJeffrey S Berger, Deepak L Bhatt, Christopher P Cannon, et al.
Regulatory Toxicology and Pharmacology : RTP|October 13, 2000
Concordance of the toxicity of pharmaceuticals in humans and in animalsH Olson, G Betton, D Robinson, et al.
The American Journal of Cardiology|January 21, 2014
Comparison of intermediate-term outcomes of coronary artery bypass grafting versus drug-eluting stents for patients ≥75 years of ageEdward L Hannan, Ye Zhong, Peter B Berger, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 21, 2012
In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registryPaul H Tolerico, David J Cohen, Neal S Kleiman, et al.
The American Journal of Cardiology|November 25, 2010
Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trialJames C Blankenship, Kimberly A Skelding, Thomas D Scott, et al.
Nature Immunology|September 7, 2010
SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophagesScott B Berger, Xavier Romero, Chunyan Ma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 5, 2013
One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trialStefanie Schulz, Adnan Kastrati, Miroslaw Ferenc, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 1, 2023
Impact of COVID-19 on percutaneous coronary intervention utilization and mortality in New YorkEdward L Hannan, Ye Zhong, Kimberly Cozzens, et al.
Pageof 78